HF 1183

  • Minnesota House Bill
  • 2021-2022 Regular Session
  • Introduced in House Feb 18, 2021
  • House
  • Senate
  • Governor

Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.

Votes


No votes to display

Actions


Apr 09, 2021

House

Author stricken Boe

Mar 25, 2021

House

Author added Greenman

Mar 11, 2021

House

Committee report, to adopt and re-refer to Ways and Means

Mar 08, 2021

House

Author added Klevorn

Mar 04, 2021

House

Author added Bierman

House

Committee report, to adopt as amended and re-refer to State Government Finance and Elections

Feb 25, 2021

House

Author added Boe

House

Committee report, to adopt as amended and re-refer to Health Finance and Policy

Feb 18, 2021

House

Introduction and first reading, referred to Commerce Finance and Policy

Bill Text

Bill Text Versions Format
Introduction APPLCATION/PDF HTML
1st Engrossment APPLCATION/PDF HTML
2nd Engrossment APPLCATION/PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Minnesota Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.